Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cornea limbal stem cells + corneal stromal stem cells
- Development stage
- Unknown
- Lead developer
- Zhongshan Ophthalmic Center
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Ophthalmic, Implant
01
Overview
Cornea limbal stem cells + corneal stromal stem cells is an autologous cell-based therapy under investigation for the treatment of unilateral limbal stem cell deficiency (LSCD), particularly cases caused by chemical injury. The therapy involves the co-transplantation of two distinct autologous stem cell populations: limbal stem cells (LSCs), which are epithelial progenitor cells harvested from the patient's healthy contralateral eye to reconstruct the corneal surface, and corneal stromal stem cells (CSSCs), which are stromal progenitor cells capable of differentiating into keratocytes to regenerate the corneal stroma. Developed by the Zhongshan Ophthalmic Center at Sun Yat-sen University, the cells are expanded ex vivo under serum-free conditions. The treatment aims to restore corneal transparency and visual function by reconstructing both the epithelial and stromal layers of the damaged cornea.
- Other names
- autologous limbal stem cells + corneal stromal stem cellsLSC + CSSC co-transplantation
Beyond the preview
Go deeper on cornea limbal stem cells + corneal stromal stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cornea limbal stem cells + corneal stromal stem cells.